140 related articles for article (PubMed ID: 36446084)
1. Design and Optimization of an α-Helical Bundle Dimer Cell-Penetrating Peptide for
Hyun S; Kim D; Cho J; Jeong D; Chung DH; Yu J
Bioconjug Chem; 2022 Dec; 33(12):2420-2427. PubMed ID: 36446084
[TBL] [Abstract][Full Text] [Related]
2. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Kim S; Hyun S; Lee Y; Lee Y; Yu J
Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521
[TBL] [Abstract][Full Text] [Related]
3. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
4. Development of Hydrophobic Cell-Penetrating Stapled Peptides as Drug Carriers.
Tsuchiya K; Horikoshi K; Fujita M; Hirano M; Miyamoto M; Yokoo H; Demizu Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511527
[TBL] [Abstract][Full Text] [Related]
5. Photoswitching of Cell Penetration of Amphipathic Peptides by Control of α-Helical Conformation.
Kim GC; Ahn JH; Oh JH; Nam S; Hyun S; Yu J; Lee Y
Biomacromolecules; 2018 Jul; 19(7):2863-2869. PubMed ID: 29856603
[TBL] [Abstract][Full Text] [Related]
6. Development of helix-stabilized cell-penetrating peptides containing cationic α,α-disubstituted amino acids as helical promoters.
Yamashita H; Misawa T; Oba M; Tanaka M; Naito M; Kurihara M; Demizu Y
Bioorg Med Chem; 2017 Mar; 25(6):1846-1851. PubMed ID: 28190655
[TBL] [Abstract][Full Text] [Related]
7. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
8. Effect of helicity and hydrophobicity on cell-penetrating ability of arginine-rich peptides.
Oba M; Nakajima S; Misao K; Yokoo H; Tanaka M
Bioorg Med Chem; 2023 Aug; 91():117409. PubMed ID: 37441862
[TBL] [Abstract][Full Text] [Related]
9. A dimeric α-helical cell penetrating peptide mounted with an HER2-selective affibody.
Chong SE; Lee D; Oh JH; Kang S; Choi S; Nam SH; Yu J; Koo H; Lee Y
Biomater Sci; 2021 Nov; 9(23):7826-7831. PubMed ID: 34812802
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides.
Soleymani-Goloujeh M; Nokhodchi A; Niazi M; Najafi-Hajivar S; Shahbazi-Mojarrad J; Zarghami N; Zakeri-Milani P; Mohammadi A; Karimi M; Valizadeh H
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):91-103. PubMed ID: 29258339
[TBL] [Abstract][Full Text] [Related]
11. A novel amphipathic cell-penetrating peptide based on the N-terminal glycosaminoglycan binding region of human apolipoprotein E.
Ohgita T; Takechi-Haraya Y; Nadai R; Kotani M; Tamura Y; Nishikiori K; Nishitsuji K; Uchimura K; Hasegawa K; Sakai-Kato K; Akaji K; Saito H
Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):541-549. PubMed ID: 30562499
[TBL] [Abstract][Full Text] [Related]
12. Multimeric Amphipathic α-Helical Sequences for Rapid and Efficient Intracellular Protein Transport at Nanomolar Concentrations.
Oh JH; Chong SE; Nam S; Hyun S; Choi S; Gye H; Jang S; Jang J; Hwang SW; Yu J; Lee Y
Adv Sci (Weinh); 2018 Aug; 5(8):1800240. PubMed ID: 30128238
[TBL] [Abstract][Full Text] [Related]
13. Effects of Substituting Disubstituted Amino Acids into the Amphipathic Cell Penetrating Peptide Pep-1.
Kato T; Numa H; Nakamachi M; Asano A; Doi M
Chem Pharm Bull (Tokyo); 2022; 70(11):812-817. PubMed ID: 36328523
[TBL] [Abstract][Full Text] [Related]
14. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
16. Peptide internalization enabled by folding: triple helical cell-penetrating peptides.
Shinde A; Feher KM; Hu C; Slowinska K
J Pept Sci; 2015 Feb; 21(2):77-84. PubMed ID: 25524829
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
[TBL] [Abstract][Full Text] [Related]
18. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
Kardani K; Bolhassani A
PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823
[TBL] [Abstract][Full Text] [Related]
19. [Peptide Foldamers: Structural Control and Cell-penetrating Ability].
Oba M
Yakugaku Zasshi; 2019; 139(4):599-608. PubMed ID: 30930395
[TBL] [Abstract][Full Text] [Related]
20. Intracellular delivery of immunoglobulin G at nanomolar concentrations with domain Z-fused multimeric α-helical cell penetrating peptides.
Chong SE; Oh JH; Min K; Park S; Choi S; Ahn JH; Chun D; Lee HH; Yu J; Lee Y
J Control Release; 2021 Feb; 330():161-172. PubMed ID: 33340565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
